Country Profile

Japan

Japan is a significant market for Indian pharmaceutical exports — $247M in FY 2025–26, with 2.0× growth over the past decade. Medicine Ingredients accounts for 52% of shipments, with vaccines contributing $507K. The compound annual growth rate since FY2015 stands at 6.6%.

🇯🇵 $247M · 2.0× growth since FY2015 · 6.6% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$247M
Exports FY2025–26 DGCIS
2.0×
Growth FY2015→2026
6.6%
CAGR FY2015→2026
52%
Medicine Ingredients Share
5
Product Categories Supplied
Japan is a significant market for Indian pharmaceutical exports — $247M in FY 2025–26, with 2.0× growth over the past decade. Medicine Ingredients accounts for 52% of shipments, with vaccines contributing $507K. The compound annual growth rate since FY2015 stands at 6.6%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $127M (51.7%) Medicines $110M (44.5%) Traditional & Herbal $5.75M (2.3%) Surgical & Hospital Supplies $3.13M (1.3%) Vaccines $507K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Japan in the RBI overseas direct investment dataset (2011–2026).